epTools is a clinical decision support app for cardiologists, providing arrhythmia localization algorithms and risk assessment calculators on iOS.
Product velocity
Maintenance
Daily rank 🇺🇸
#57
▲22Medical · paid
Sentiment
4.8
507 reviews
Nemesis
Kardia
The App DNA
What makes this app unique?
Clinicians hire the app to reduce diagnostic uncertainty during complex cardiac procedures, replacing manual reference searches with an automated, algorithm-driven decision path.
For Healthcare professionals and cardiologists specializing in the evaluation and management of heart rhythm disorders.
What does it look like?
Key features
Decision-path tools for identifying arrhythmia substrates using established medical research.
Exports graphical decision-path visualizations to the device photo album.
Tool for creating and sharing preoperative plans via text or email.
How much does it cost?
Paid model anchored at $19.99, targeting professional medical users who require specialized clinical decision support tools.
Velocity
Maintenance developmentShow more...
5 versions in history. Development pace: maintenance.
Who built it?
Busy Being Born Solutions
3 apps tracked · Medical
Magnet Master
epTools LiteUser Sentiment
What do users think recently?
Review voice lately leans thrilled. Users appreciate clinical decision support tools provide immediate utility for electrophysiologists during active patient cases.
How are ratings & reviews evolving?
What users say, by theme
- Clinical decision support tools provide immediate utility for electrophysiologists during active patient cases
- Subjective user experience expectations occasionally fall short of high clinical utility standards
10 of 10 recent reviews analyzed · moderate confidence · Thrilled overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for epTools
How's the Medical market?
epTools maintains a niche presence in the Medical category, with rankings in the US hovering around #54 Paid. The disparity between its high rating (4.8) and volatile grossing ranks indicates that while the tool is highly valued, the $19.99 entry price limits its ability to capture consistent, high-volume revenue.
Read the market outlookThe rivals identified
By AliveCor, Inc.
Dominates the cardiac rhythm monitoring space with a massive user base and professional-grade hardware integration.
- Integrates directly with proprietary ECG hardware to provide clinical-grade diagnostic data for patients and providers.
- Maintains a massive ecosystem of professional-grade cardiac monitoring tools that far exceeds simple reference guides.
- Leverages a hardware-software feedback loop that creates significant switching costs for both patients and clinicians.
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for epTools
Where is it heading?
The clinical reference market is shifting toward unified, connected platforms that integrate directly into the physician's workflow. epTools remains a trusted, static reference, but its growth will stagnate unless it evolves from a standalone tool into a connected component of the clinical ecosystem.
- Frequent additions of new risk scores (BLISTER, AHA) demonstrate active maintenance of clinical relevance for the professional user base.
- The lack of cloud-based data portability limits the app's integration into modern hospital workflows, creating a churn risk against connected competitors.
The SWOT
- Specialized arrhythmia algorithm library creates high switching costs for electrophysiologists
- Clinical reference authority justifies the $19.99 price point
- Integration with hospital EHR systems could unlock B2B distribution channels
- Wearable data integration would bridge the gap between reference and monitoring
Next best moves
Ship cloud-sync for patient plans because lack of data portability is a workflow bottleneck → increase retention
+ 1 more prioritized moveThe counter-intuitive read
The app's $19.99 one-time price is not a weakness but a moat…
Read the full takeFeature gaps
Real-time clinical collaboration (available in Spruce Health) +1
Since the last report: The app has transitioned from a basic reference tool to a specialized clinical utility facing pressure from connected, subscription-based competitors.
Bottom line
epTools provides essential clinical utility through its specialized algorithm library, but it risks obsolescence against connected, subscription-based platforms, so the PM should prioritize cloud-syncing to secure its place in the modern clinical workflow.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated